The first Iovance Biotherapeutics trade was made in Q2 2019.
Since then Steven Cohen bought shares four more times and sold shares on six occasions. The investor completely sold their stake between Q2 2023 and Q4 2023.
Avg closing price
Price range
Sold -1.41 Million shares
Q4 2023
Avg closing price
$5.23
Price range
$3.30
-
$8.89
Sold 81.9% shares (-6.37 Million shares)
Q3 2023
Avg closing price
$6.53
Price range
$4.44
-
$8.79
Sold 11.5% shares (-1.01 Million shares)
Q2 2023
Avg closing price
$7.16
Price range
$5.36
-
$9.06
New holding (+8.8 Million shares)
Q1 2023
Avg closing price
$6.90
Price range
$5.53
-
$8.22
Sold -444 Thousand shares
Q4 2020
Avg closing price
$39.70
Price range
$28.04
-
$50.26
Sold 68.8% shares (-978 Thousand shares)
Q3 2020
Avg closing price
$30.66
Price range
$27.75
-
$36.30
Sold 53.6% shares (-1.64 Million shares)
Q2 2020
Avg closing price
$32.87
Price range
$27.21
-
$41.00
Increased shares by 9.3% (+260 Thousand shares)
Q1 2020
Avg closing price
$26.51
Price range
$19.54
-
$38.85
Increased shares by 258.2% (+2.02 Million shares)
Q4 2019
Avg closing price
$22.75
Price range
$17.95
-
$29.41
Increased shares by 76.5% (+339 Thousand shares)
Q3 2019